Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,140.60
-8.50 (-0.74%)
Nov 6, 2025, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 667.4 billion as of November 6, 2025. Its market cap has decreased by -22.47% in one year.
Market Cap
667.40B
Enterprise Value
667.61B
Revenue
323.94B
Ranking
n/a
PE Ratio
19.50
Stock Price
1,140.60
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 667.40B, an increase of 6,849.70%. That is a compound annual growth rate of 19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 667.40B | -13.89% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.09T |
| Divi's Laboratories | 1.81T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.13T |
| Mankind Pharma | 990.41B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 778.14B |
| Alkem Laboratories | 672.97B |